References
- Aiken AH, Chang SM, Larson D, Butowski N, Cha S : Longitudinal magnetic resonance imaging features of glioblastoma multiforme treated with radiotherapy with or without brachytherapy. Int J Radiat Oncol Biol Phys 72 : 1340-1346, 2008 https://doi.org/10.1016/j.ijrobp.2008.02.078
- Artzi M, Bokstein F, Blumenthal DT, Aizenstein O, Liberman G, Corn BW, et al. : Differentiation between vasogenic-edema versus tumor-infiltrative area in patients with glioblastoma during bevacizumab therapy: a longitudinal MRI study. Eur J Radiol 83 : 1250-1256, 2014 https://doi.org/10.1016/j.ejrad.2014.03.026
- Arvinda HR, Kesavadas C, Sarma PS, Thomas B, Radhakrishnan VV, Gupta AK, et al. : Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging. J Neurooncol 94 : 87-96, 2009 https://doi.org/10.1007/s11060-009-9807-6
- Barajas RF Jr, Chang JS, Segal MR, Parsa AT, McDermott MW, Berger MS, et al. : Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 253 : 486-496, 2009 https://doi.org/10.1148/radiol.2532090007
- Bisdas S, Naegele T, Ritz R, Dimostheni A, Pfannenberg C, Reimold M, et al. : Distinguishing recurrent high-grade gliomas from radiation injury: a pilot study using dynamic contrast-enhanced MR imaging. Acad Radiol 18 : 575-583, 2011 https://doi.org/10.1016/j.acra.2011.01.018
- Bobek-Billewicz B, Stasik-Pres G, Hebda A, Majchrzak K, Kaspera W, Jurkowski M : Anaplastic transformation of low-grade gliomas (WHO II) on magnetic resonance imaging. Folia Neuropathol 52 : 128-140, 2014
- Bobek-Billewicz B, Stasik-Pres G, Majchrzak H, Zarudzki L : Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy. Folia Neuropathol 48 : 81-92, 2010
- Chung WJ, Kim HS, Kim N, Choi CG, Kim SJ : Recurrent glioblastoma: optimum area under the curve method derived from dynamic contrastenhanced T1-weighted perfusion MR imaging. Radiology 269 : 561- 568, 2013 https://doi.org/10.1148/radiol.13130016
- Danchaivijitr N, Waldman AD, Tozer DJ, Benton CE, Brasil Caseiras G, Tofts PS, et al. : Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation? Radiology 247 : 170-178, 2008 https://doi.org/10.1148/radiol.2471062089
- Di Costanzo A, Scarabino T, Trojsi F, Popolizio T, Bonavita S, de Cristofaro M, et al. : Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach. Radiol Med 119 : 616-624, 2014 https://doi.org/10.1007/s11547-013-0371-y
- Fatterpekar GM, Galheigo D, Narayana A, Johnson G, Knopp E : Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum--use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI. AJR Am J Roentgenol 198 : 19-26, 2012 https://doi.org/10.2214/AJR.11.7417
- Gomez-Rio M, Rodriguez-Fernandez A, Ramos-Font C, Lopez-Ramirez E, Llamas-Elvira JM : Diagnostic accuracy of 201Thallium-SPECT and 18FFDG-PET in the clinical assessment of glioma recurrence. Eur J Nucl Med Mol Imaging 35 : 966-975, 2008 https://doi.org/10.1007/s00259-007-0661-5
- Guillevin R, Herpe G, Verdier M, Guillevin C : Low-grade gliomas: The challenges of imaging. Diagn Interv Imaging 95 : 957-963, 2014 https://doi.org/10.1016/j.diii.2014.07.005
- Hlaihel C, Guilloton L, Guyotat J, Streichenberger N, Honnorat J, Cotton F : Predictive value of multimodality MRI using conventional, perfusion, and spectroscopy MR in anaplastic transformation of low-grade oligodendrogliomas. J Neurooncol 97 : 73-80, 2010 https://doi.org/10.1007/s11060-009-9991-4
- Kahn D, Follett KA, Bushnell DL, Nathan MA, Piper JG, Madsen M, et al. : Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET. AJR Am J Roentgenol 163 : 1459-1465, 1994 https://doi.org/10.2214/ajr.163.6.7992747
- Kim HS, Goh MJ, Kim N, Choi CG, Kim SJ, Kim JH : Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility. Radiology 273 : 831-843, 2014 https://doi.org/10.1148/radiol.14132868
- Kim YH, Oh SW, Lim YJ, Park CK, Lee SH, Kang KW, et al. : Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI. Clin Neurol Neurosurg 112 : 758-765, 2010 https://doi.org/10.1016/j.clineuro.2010.06.005
- Law M, Young RJ, Babb JS, Peccerelli N, Chheang S, Gruber ML, et al. : Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrastenhanced perfusion MR imaging. Radiology 247 : 490-498, 2008 https://doi.org/10.1148/radiol.2472070898
- Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG : Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8 : 1277-1280, 1990 https://doi.org/10.1200/JCO.1990.8.7.1277
- Narang J, Jain R, Arbab AS, Mikkelsen T, Scarpace L, Rosenblum ML, et al. : Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion. Neuro Oncol 13 : 1037-1046, 2011 https://doi.org/10.1093/neuonc/nor075
- Prat R, Galeano I, Lucas A, Martinez JC, Martin M, Amador R, et al. : Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas. J Clin Neurosci 17 : 50-53, 2010 https://doi.org/10.1016/j.jocn.2009.02.035
- Raimbault A, Cazals X, Lauvin MA, Destrieux C, Chapet S, Cottier JP : Radionecrosis of malignant glioma and cerebral metastasis: A diagnostic challenge in MRI. Diagn Interv Imaging 95 : 985-1000, 2014 https://doi.org/10.1016/j.diii.2014.06.013
- Seeger A, Braun C, Skardelly M, Paulsen F, Schittenhelm J, Ernemann U, et al. : Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease. Acad Radiol 20 : 1557-1565, 2013 https://doi.org/10.1016/j.acra.2013.09.003
- Shah AH, Snelling B, Bregy A, Patel PR, Tememe D, Bhatia R, et al. : Discriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality? J Neurooncol 112 : 141-152, 2013 https://doi.org/10.1007/s11060-013-1059-9
- Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, et al. : Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28 : 1963-1972, 2010 https://doi.org/10.1200/JCO.2009.26.3541
Cited by
- Pseudoprogression as an adverse event of glioblastoma therapy vol.6, pp.12, 2017, https://doi.org/10.1002/cam4.1242
- Effect of age-dependent bone electron density on the calculated dose distribution from kilovoltage and megavoltage photon and electron radiotherapy in paediatric MRI-only treatment planning vol.91, pp.1081, 2017, https://doi.org/10.1259/bjr.20170511
- Magnetic Resonance Perfusion Imaging in the Diagnosis of High-Grade Glioma Progression and Treatment-Related Changes: A Systematic Review vol.8, pp.3, 2017, https://doi.org/10.4236/ojmn.2018.83024
- Arterial spin labeling in the grading of brain gliomas: could it help? vol.51, pp.1, 2017, https://doi.org/10.1186/s43055-020-00352-6
- Diagnostic accuracy of magnetic resonance imaging in detection of intra-axial gliomas vol.37, pp.1, 2017, https://doi.org/10.12669/pjms.37.1.2489